References
Danese S, Argollo M, Le Berre C,
Peyrin-Biroulet L (2019). JAK selectivity for inflammatory bowel disease
treatment: does it clinically matter? Gut68 (10): 1893-1899.
Fakih R, Matiello M, Chitnis T,
Stankiewicz JM (2018). Efficacy and safety of mycophenolate mofetil in
progressive multiple sclerosis patients. Journal of Neurology265 (11): 2688-2694.
Heymann F, Hamesch K, Weiskirchen R,
Tacke F (2015). The concanavalin A model of acute hepatitis in mice.Laboratory Animals 49: 12-20.
Kumar V (2013). NKT-cell subsets:
Promoters and protectors in inflammatory liver disease. Journal of
Hepatology 59 (3): 618-620.
Lee CL, Sit WH, Jiang PP, So IWY, Wan
JMF (2008). Polysaccharopeptide mimics ciclosporin-mediated Th1/Th2
cytokine balance for suppression of activated human T cell proliferation
by MAPKp38 and STAT5 pathways. Journal of Pharmacy and
Pharmacology 60 (11): 1491-1499.
Mack CL, Adams D, Assis DN, Kerkar N,
Manns MP, Mayo MJ, et al. (2019). Diagnosis and management of
autoimmune hepatitis in adults and children: 2019 practice guidance and
guidelines from the American Association for the study of liver
diseases. Hepatology (Baltimore, Md.) .
Manns MP, Lohse AW, Vergani D (2015).
Autoimmune hepatitis - Update 2015. Journal of Hepatology62: S100-S111.
Mattner J (2013). Natural killer T
(NKT) cells in autoimmune hepatitis. Current Opinion in
Immunology 25 (6): 697-703.
Mieli-Vergani G, Vergani D, Czaja AJ,
Manns MP, Krawitt EL, Vierling JM, et al. (2018). Autoimmune
hepatitis. Nature Reviews Disease Primers 4: 21.
Mizuhara H, O’Neil E, Seki N, Ogawa
T, Kusunoki C, Otsuka K, et al. (1994). T cell
activation-associated hepatic injury: Mediation by tumor necrosis
factors and protection by interleukin 6. Journal of Experimental
Medicine 179 (5): 1529-1537.
Nakaya M, Hashimoto M, Nakagawa R,
Wakabayashi Y, Ishizaki T, Takada I, et al. (2009). SOCS3 in T
and NKT cells negatively regulates cytokine production and ameliorates
ConA-induced hepatitis. Journal of immunology183 (11): 7047-7053.
Onodera H, Hasegawa A, Tsumagari N,
Nakai R, Ogawa T, Kanda Y (2004). MPC1001 and its analogues: New
antitumor agents from the fungus Cladorrhinum species. Organic
Letters 6 (22): 4101-4104.
Ooike M, Nozawa K, Kawai KI (1997).
An epitetrathiodioxopiperazine related to emestrin from Emericella
foveolata. Phytochemistry 46 (1): 123-126.
Salvi V, Gianello V, Tiberio L,
Sozzani S, Bosisio D (2019). Cytokine Targeting by miRNAs in Autoimmune
Diseases. Frontiers in immunology 10: 15.
Santodomingo-Garzon T, Swain MG
(2011). Role of NKT cells in autoimmune liver disease.Autoimmunity Reviews 10 (12): 793-800.
Senaldi G, Portmann B, Mowat AP,
Mieli-Vergani G, Vergani D (1992). Immunohistochemical features of the
portal tract mononuclear cell infiltrate in chronic aggressive
hepatitis. Archives of disease in childhood67 (12): 1447-1453.
Sharma M, Sharma R (2016). Drugs and
drug intermediates from fungi: Striving for greener processes.Critical Reviews in Microbiology 42 (2):322-338.
Takeda K, Hayakawa Y, Van Kaer L,
Matsuda H, Yagita H, Okumura K (2000a). Critical contribution of liver
natural killer T cells to a murine model of hepatitis. Proceedings
of the National Academy of Sciences of the United States of America97 (10): 5498-5503.
Takeda K, Hayakawa Y, Van Kaer L,
Matsuda H, Yagita H, Okumura K (2000b). Critical contribution of liver
natural killer T cells to a murine model of hepatitis. Proceedings
of the National Academy of Sciences of the United States of America97 (10): 5498-5503.
Tiegs G, Hentschel J, Wendel A
(1992). A T cell-dependent experimental liver injury in mice inducible
by concanavalin A. The Journal of clinical investigation90 (1): 196-203.
Vergani D, Mieli-Vergani G (2012).
Cutting Edge Issues in Autoimmune Hepatitis. Clinical Reviews in
Allergy & Immunology 42 (3): 309-321.
Wang HX, Liu M, Weng SY, Li JJ, Xie
C, He HL, et al. (2012). Immune mechanisms of Concanavalin A
model of autoimmune hepatitis. World Journal of Gastroenterology18 (2): 119-125.
Watanabe Y, Morita M, Akaike T
(1996). Concanavalin A induces perforin-mediated but not Fas-mediated
hepatic injury. Hepatology 24 (3): 702-710.
Yan JB, Jie ZL, Hou LF, Wanderley JL,
Soong L, Gupta S, et al. (2011). Parenchymal Expression of CD40
Exacerbates Adenovirus-Induced Hepatitis in Mice. Hepatology53 (5): 1455-1467.
Zhou YQ, Weng XF, Dou R, Tan XS,
Zhang TT, Fang JB, et al. (2017). Betulin from Hedyotis
hedyotidea ameliorates concanavalin A-induced and T cell-mediated
autoimmune hepatitis in mice. Acta Pharmacologica Sinica38 (2): 201-210.